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Abstract 
The objective of the present study was to determine the reliability and validity of the 
Persian translation of the PedsQL™ 4.0 Generic Core Scales Young Adult Version in 
an Iranian sample of young adult patients with rheumatoid arthritis (RA). 197 young 
adult patients with RA completed the 23-item PedsQL™ and the 36-item SF-36 
Health Survey. Disease activity based on Disease Activity Score 28 (DAS28) was 
also measured. Internal consistency and test–retest reliability, as well as construct, 
discriminant and convergent validity were tested. Confirmatory factor analysis (CFA) 
was used to verify the original factor structure of the PedsQL™. Also, responsiveness 
to change in PedsQL™ scores over time was assessed. Cronbach’s alpha coefficients 
ranged from α=0.82 to α=0.91. Test-retest reproducibility was satisfactory for all 
scales and the total scale score. The PedsQL proved good convergent validity with the 
SF-36. The PedsQL distinguished well between young adult patients and healthy 
young adults and also RA groups with different comorbidities. The CFA did not 
confirm the original four-factor model, instead analyses revealed a best-fitting five-
factor model for the PedsQL™ Young Adult Version. Repeated-measures analysis of 
variance indicated that the PedsQL scale scores for young adults increased 
significantly over time. The Persian translation of the PedsQL™ 4.0 Generic Core 
Scales Young Adult Version demonstrated good psychometric properties in young 
adult patients with RA and can be recommended for the use in RA research in Iran. 
 Keywords: PedsQL, quality of life, rheumatoid arthritis, young adults, patient 
reported outcomes, Iran, psychometric validation 
 
 
Introduction  
Rheumatoid arthritis (RA) is a chronic autoimmune disease that leads to inflammation 
of the joints and surrounding tissues [1]. RA may also affect other organs such as 
heart, liver, and etc. The etiology of RA remains unknown [1-2]. 
The fatigue, pain, stiffness and joint swelling as a result of RA is recognized as a 
significant cause of patients' functional disability [3].  It was estimated that RA affects 
1% of the adult American population [4]. In Europe, the incidence rate of RA varies 
between a low 8.8/100000 for France to a high 24-36/100000 incidence for 
Scandinavian countries [5-6]. A recent study in Iran revealed a prevalence of RA of 
0.19% and 0.33% for rural and urban areas, respectively [7-8]. The prevalence of the 
RA increases with age, and there is higher incidence in women compared with men 
[9]. Although the burden of RA is substantial for pediatric and adults patients [9], RA 
has been shown to have greater effects on patient's activities, mental health and pain 
in younger patients [10]. Chronic diseases, such as RA, in youth are associated with 
high pain, disability, depression, impaired work and school functioning [10, 12-
14].Furthermore, being a young adult with RA predicts future disability, pain, and 
well being in adulthood [11]. There is a general agreement among health care 
professionals that considering symptoms of RA alone as medical outcomes are not 
sufficient. The concept of quality of life has been increasingly used not only for 
assessing daily clinical practice but has recently also been recognized as an important 
disease and health related outcome measure [15-16]. Health related quality of life 
(HRQOL) is defined by the World Health Organization (WHO) as "an individual’s 
perception of their position in life in the context of the culture and value systems in 
which they live and in relation to their goals, expectations, and standards and 
concerns" [17]. HRQOL is a multidimensional concept which encompasses physical 
health, psychological state, level of independence, social relationships, and people's 
relationships to salient features of their environment [17]. Assessment of HRQOL 
helps following the trends of improvements, the assessment of treatment effects, and 
the identification of strategies to prevent adverse complications in RA patients [18].  
Several generic HRQOL assessment instrument exist, such as the Medical Outcomes 
Study 36- Item Short-Form Health Survey (MOS SF-36) [19].Disease-specific 
measures to assess HRQOL among patients with RA include the Stanford Health 
Assessment Questionnaire (HAQ) [20-21] and the Arthritis Impact Measurement 
Scales (AIMS) [22]. While disease specific measures cover all the specific factors of 
RA (i.e. clinical features of RA), generic measures have the ability to compare health 
status in any population regardless of the disease or condition [23-24]. Although, the 
SF-36 has been widely used to assess HRQOL in patients with RA [24], it does not 
fully consider all aspects of the patient's quality of life. A recent study revealed that 
limited activity at school and work place were major complains of adolescent patients 
suffering from RA [25]. The Pediatric Quality of Life Inventory (PedsQL TM) was 
originally developed by Varni et al and used to assess health conditions in pediatrics 
with chronic disease [26]. In contrast to the SF-36, the PedsQL includes school/work 
functioning as an important aspect of patients' life. The PedsQL was originally used in 
children aged 2 to18 years and their parents. The PedsQL has been widely used for 
various diseases with acceptable measurement properties. Recently, efforts have been 
made to provide continuity of in assessing HRQOL assessment in young patients after 
the age of 18 [27] with the PedsQL™ 4.0 Generic Core Scales Young Adult Version 
was administrated in a U.S university student population (aged 18 to25) [27] and 
validation analyses confirmed a high internal consistency and could successfully 
differentiate between healthy people and youth with chronic diseases [27].    
To the best of our knowledge, there is no study that assesses HRQOL in young adult 
patients with RA in Iran. The aim of this study was therefore to cross-culturally adapt 
the PedsQL and to assess HRQOL in Persian-speaking RA patients. 
 
Methods 
Participants 
From February 2010 to April 2011, n=197patients with RA who had been referred to 
from the rheumatology clinic at the Boo-Ali hospital were recruited. An expert 
rheumatologist confirmed the diagnosis of RA according to the criteria set by the  
American College of Rheumatology [28]. Criteria for study inclusion were: age from 
18 to 25; a confirmed diagnosis of RA by a rheumatologist; willingness to participate 
in the study; fluency in written and spoken Persian. The study protocol was approved 
by the research ethics committee of the Qazvin University of Medical Sciences. All 
participants gave their written informed consent.        
 
Measurements 
A demographic questionnaire was designed to collect information on basic 
demographic factors such as age, gender and educational status. Furthermore, clinical 
variables including duration of RA, number of tender and swollen joint, and 
erythrocyte sedimentation rate (ESR) were also evaluated. 
 
Disease Activity Score-28 (DAS28) 
Disease activity was measured by the DAS28 [29]. The DAS28 is a useful measure to 
evaluate inflammatory disease activity in RA and includes four parts:1) number of 
tender joints 2) number of swollen joints 3) Erythrocyte Sedimentation Rate (ESR) in 
blood and 4) general health assessment using a visual analogue scale (VAS). VAS (0-
100) is a simple tool to evaluate pain severity as reported by patients. The DAS28 
total score can be generated by using the following formula: =0.56*√ (tender joints) + 
0.28* √ (swollen joints) + 0.70*Ln(ESR/CRP) + 0.014*VAS. 
 
The SF-36 
 The SF-36 is a general questionnaire used to assess HRQOL [19]. It has been used 
successfully in chronic diseases including RA [30-31] .It includes 36 items and covers 
eight subscales including physical functioning (PF), role limitations due to physical 
health (RP), bodily pain (BP), general health perception (GH), social functioning 
(SF), role limitations due to emotional problems (RE), vitality (VT), and mental 
health (MH) [19]. The SF-36 has been translated into various languages and is also 
available in Persian. Measurement properties of the Persian version were previously 
confirmed in a population study comprising 4163 healthy Iranian adults over 15 years 
old [32].  
 
The PedsQL™ 4.0 Generic Core Scales Young Adult Version 
The PedsQL™ 4.0 Generic Core Scales Young Adult Version has 23 items with four 
subscales including: Physical Functioning (eight items); Emotional Functioning (five 
items); Social Functioning (five items); and Work/School Functioning (five items) 
[27]. These items are similar to those in the PedsQL™4.0 Generic Core Scales 
Adolescent Version (i.e. 13-18 years old) [33]. All items of  the PedsQL™ 4.0 
Generic Core Scales Young Adult Version score  on a five-point Likert scale, ranging 
from “never” (0) to  “almost always” (4). The scores are linearly transformed on a 
scale from 0 (worst condition) to 100 (best condition) [27, 33]. Besides the four 
subscales, the PedsQL™ 4.0 Generic Core Scales Young Adult Version has two 
summary scores: the physical health summary score (8 items) and the psychosocial 
health summary score (15 items). To create the summary scores, the mean is 
computed as the sum of the specific scale items divided by the number of items. 
 
 
Procedure   
The patients completed the set of questionnaires at baseline after agreeing to 
participate in the study. Demographic and clinical data were collected at the same 
time. Two weeks later, the patients were asked again to complete the PedsQL™ 4.0 
Generic Core Scales Young Adult Version to ensure reliability of the instrument. 
However, nine patients did not complete the questionnaire dropped out and did not 
complete the questionnaire for the second time. 
 
Translation  
After receiving permission from the MAPI research trust, the PedsQL™ 4.0 Generic 
Core Scales Young Adult Version was translated into Persian by two local English-
Persian bilingual translators (Forward Translation). Next, the translators discussed 
their translations to achieve a reconciled version.  
Then, the first reconciled forward version was back translated into the source 
language (i.e. English) by a native English speaking, translator. The translator was not 
aware of the original version and had no access to the original English questionnaire 
version. The back-translated version was sent to the developer for review and 
comment. In the next step, the backward translated version of the PedsQL™ was 
compared with the original English version was made and necessary modifications 
were made. 
This second version of the translated PedsQL™ was piloted in a sample of N=11 
patients with RA A cognitive interviewing methodology with respondent debriefing 
technique was used for this step. Afterwards, the PedsQL™ 4.0 Generic Core Scales 
Young Adult Version was revised based on the results of the cognitive interviews. In 
the end, the resulting final version of the translated PedsQL™ 4.0 Generic Core 
Scales Young Adult Version was administrated to a sample of n=197 patients with 
RA (field testing).         
 
Data analysis 
Data were analyzed using SPSS version 16 and LISREL version 8.80.  
Ceiling effects (i.e. the percentage of scores at the maximum possible scores) and 
floor effects (i.e. the percentage of scores at the minimum possible scores) were 
computed to assess the range of measurement. Floor and ceiling effects were regarded 
as being present if more than 15% of the responders reported highest or lowest 
possible scores [34].     
Reliability was assessed in two ways; 1) internal consistency; internal consistency 
was evaluated by calculation of Cronbach's alpha Coefficient on the four subscales 
and total scores. A Cronbach's alpha 0.70 or higher indicates acceptable internal 
consistency [35]. 2) test-retest reliability was evaluated by calculating intra-class 
correlation coefficients (ICCs) for the 2 week interval. ICCs ≤ 0.40, 0.41-0.59, and ≥ 
0.60 are considered small, medium and large, respectively [36]. 
Convergent validity was examined by computing intercorrelations between the 
PedsQL™ subscales and the SF-36 subscales. It was assumed that the PedsQL™ 
correlated positively with the SF-36. 
Known group comparison was used to assess discriminant validity of the PedsQL 4.0 
Generic Core Scales young adult version. N=1803 healthy young people were 
randomly selected from Qazvin University of Medical Sciences with similar age and 
sex distribution. Based on previous studies it was assumed that healthy people 
reported higher scores than people with RA [37-39]. According to the previous 
studies, HRQOL are affected by comorbidities [40-41]. Thus, patients with at least 
one medical comorbidity were compared with those patients reporting no 
comorbidities based on quality of life scores. 
The factor structure of the PedsQL 4.0 Generic Core Scales young adult version was 
evaluated using confirmatory factor analysis (CFA). CFA was applied to for both 
groups (i.e. patients with RA and healthy young adults) to verify the original four-
factor structure [27, 33]. A weighted least squares (WLS) estimation method was used 
to perform the CFA. The goodness- of-fit of the model was evaluated with the 
following parameters: chi square (χ2) - an absolute fit indices that is sensitive to 
sample size,   the goodness of- fit index (GFI) , the comparative fit index (CFI) , non-
normed fit index (NNFI), Parsimony Normed Fit Index (PNFI) and Root Mean 
Square Error of Approximation (RMSEA) . GFI, NNFI and CFI ranged from 0 to 1 
and values equal or greater than 0.90 is considered acceptable fit. A RMSEA value 
less than or equal to .05 is considered acceptable. PNFI is considered as parsimonious 
fit index and ranged from 0 to 1 with higher values indicating a more parsimonious fit 
[42]. In the study, two models were tested; a four-factor model for healthy young 
adults (n=1803) and a hypothesized four-factor model for patients with RA (n= 197).  
Despite of the existing scale structure of the PedsQL (i.e. four factor structure), the 
EFA in the original study revealed an empirical five-factor structure [43]. Therefore, a 
five-factor model was specified for the CFA analyses in the current study if the 4-
factor structure did not yield a good fit.    
To examine the ability of the PedsQL 4.0 Generic Core Scales young adult version to 
detect a treatment effect, the measure was administrated to a subsample of 49 patients 
with newly diagnosed RA. The patients were prescribed either disease modifying 
antirheumatic drugs (DMARDs) or nonsteroidal anti-infl ammatory drugs (NSAIDs). 
Studies have indicated that NSAIDs can reduce pain, inflammation and stiffness in 
patients with RA [44-46]. On the other hands, the use of DMARDs has been shown to 
be effective in preventing erosive disease [46]. The patients were asked to complete 
the PedsQL at three different time points (baseline, three months and six months 
follow-up). Previous studies have recommended the use of effect size statistics for 
repeated measure designs [47]. However, effect sizes tend to be over-estimate if the 
distribution of the baseline scores is narrow. One way to avoid this problem is to use 
the standardized response mean (SRM). In this study SRM were computed to assess 
changes in the PedsQL over time (responsiveness) [48]. The SRM is obtained by 
dividing the mean change from baseline on standard deviation change. Values of 0.20, 
0.50, and 0.80 or greater were considered to represent small, moderate, and large 
degrees of responsiveness, respectively. The repeated measure analysis of variance 
was used to test the differences between values of the three measurements. Statistical 
significance level for analyses was considered to be at p < 0.05.  
 
Results 
Demographic and clinical features of the patients are shown in table 1. The majority 
of the patients were female (%79).The mean age and disease duration were 23.2 
months and 54.3 months, respectively. Minimal floor or ceiling effects were observed 
in all four subscales of the PedsQL.  
The internal consistency of the Iranian version of the PedsQL was acceptable, with 
Cronbach’s alphas ranging from 0.82 to 0.91 (Table 2).   
Test-retest reliability was good, with a high intra-class correlation coefficient for the 
two time points (Table 2).  
There were significant correlations (P<0.01) between the PedsQL scores and SF-36 
subscales (Table 3). A high correlation was observed between the PedsQL physical 
functioning scale and SF-36 physical functioning scale (r=0.75). 
Results of the discriminant analysis are summarized in Table 4. Healthy subjects had 
a significantly lower burden of disease compared with patients with RA even when 
considering adjusted-p values (i.e. Benjamini-Hochberg procedure). Furthermore, 
statistically significant differences were found in the means of the PedsQL subscales 
scores depending on comorbidity (Table 3). Patients with at least one comorbidity 
reported lower HRQOL compared with those without any comorbidity (P<0.001). 
The hypothesized four-factor structure was tested by the CFA for patient and healthy 
participant samples. The results revealed that the four-factor model did not provide an 
adequate fit for both patient groups (χ2=802.94, degree of freedom=224, P 
value<0.0001, GFI = 0.73, NNFI = 0.89, PNFI= 0.77, CFI = 0.90 and RMSEA = 
0.117) and the healthy young adult group (χ2=556.11, degree of freedom=224, P 
value<0.0001, GFI = 0.78, NNFI = 0.89, PNFI= 0.76, CFI = 0.91 and RMSEA = 
0.091). Therefore, an empirical five-factor structure as suggested by Varni et al was 
tested in which the 5-item school functioning scale splits into 3 cognitive functioning 
items and 2 missed school days items [43]. In contrast to the four-factor model, for all 
groups the model fit and comparative indices were highgest for the original 5-factor 
model (χ2=462.48, degree of freedom=220, P value<0.0001, GFI = 0.92, NNFI = 
0.94, PNFI= 0.79, CFI = 0.94 and RMSEA = 0.076 for the patient group and  
χ2=496.23, degree of freedom=220, P value<0.0001, GFI = 0.91, NNFI = 0.92, PNFI= 
0.79, CFI = 0.93 and RMSEA = 0.079 for the healthy young adult group). 
The results regarding the changes in the PedsQL subscale scores over time are 
summarized in Table 5. Repeated-measures analysis of variance revealed that the 
mean number of the PedsQL increased significantly after the 3 months and the 6 
months follow-up compared to the initial, baseline visit (Table 5). The most 
responsive subscale was work functioning with an SRM of 0.57 at 3 months and 
social functioning with a SRM of 0.70 at 6 months. Positive SRMs represent an 
improvement in quality of life over time. Generally the SRMs were small to moderate 
at 6 months follow-up, implying improvement of HRQoL occurring between 3 and 6 
months (Table 5). 
  
Discussion 
The aim of this study was to assess the psychometric properties of an Iranian version 
of the PedsQL a sample of young adult patients suffering from RA. The Iranian 
version of the PedsQL showed a high internal consistency, good test–retest reliability, 
as well as high construct, convergent, and discriminant validity. Furthermore, the 
factor structure and the questionnaires responsiveness to change over time were 
assessed in the study. 
Response variability within the population was supported by the lack of floor and 
ceiling effects. Therefore, the instrument can be used to detect health changes over 
time. The original version of the PedsQL reported similar findings for U.S university 
students with chronic health conditions [27].    
High Cronbach’s alpha coefficients for the four domains of the PedsQL confirmed 
that these domains were internally consistent. The results were in line with previous 
findings in the original validation study in the US (α= 0.71 to 0.86).  
Reproducibility of the young adult version of the PedsQL was assessed using ICC 
over two weeks. All ICCs were above 0.70 therefore demonstrating high reliability/ 
reproducibility of the questionnaire results over time. This is the first study to assess 
the reproducibility of the PedsQL™ 4.0 Generic Core Scales Young Adult Version. 
However, the stability of the PedsQL™ has been reported for different age versions 
[49- 51].  
The study indicated that the PedsQL™ correlated moderately with the SF-36 and the 
VAS. As anticipated, the physical domains of the PedsQL™ correlated moderately to 
high with the corresponding domains of the SF-36, demonstraingthat the PedsQL™ 
and the SF-36 capture similar conceptual areas. Again, these findings are consistent 
with results obtained from the initial validation study conducted on a US university 
sample [27].  
In the present study, the PedsQL™ was able to discriminate between patients with RA 
and a age and gender matched, healthy university sample. Significantly higher scores 
on the PedsQL™ could be observed for the healthy sample compared to the RA 
patient sample.  
Comorbidities can affect patient's functional ability [41]. A recent study demonstrated 
that an increasing level of functional disability is significantly associated with poorer 
quality of life in patients with RA [40]. However, in contrast to our study, mental 
functioning was not affected by comorbidity among Australian patients with RA as 
shown by an earlier epidemiologic study [40]. Using different instruments to assess 
HRQOL and using an older sample may be potential reasons for these discrepancies 
in findings.  
Contrary to the hypothesized four-factor structure, the CFA indicated a best fitting 
five-factor model of the 23 questionnaire items. There are discrepancies in the 
literature regarding the structure of the PedsQL™. Whilst a four-factor structure was  
reported in a previous study on Iranian children and adolescents with attention 
deficit/hyperactivity disorder [50], the Iranian version of PedsQL Generic Core Scales 
in adolescents supported a five-factor model, similar to the original version of the 
PedsQL [49]. Possible explanations for these divergent findings could be differences 
in demographic characteristics of the study populations, such as age, or differences in 
clinical variables.  
The PedsQL Generic Core Scales was sensitive to change after intervention over a 3 
and 6 month follow-up. At the six month follow-up, all subscales of the PedsQL 
showed significantly lower scores, indicating a significant improvement from baseline 
(all P < 0.001).  Our results were in accordance with other studies [i.e. 44-46, 52-54].           
This study has some limitations. First of all, our patients are not representative of all 
Iranian patients with RA. Therefore, the generalizability of this study may be limited. 
Thus, data should be interpreted with caution.   
 In conclusion, the Iranian version of the PedsQL™ has good psychometric properties 
and can be recommended for the use in RA research in Iran.  
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Table 1. Demographic characteristics of the rheumatoid arthritis patients  
N (%)  
23.25 (4.98) Age (mean±SD) 
 Gender  
41 (20.81%) Male  
156 (79%)  Female    
8.18(3.62) Patient's education (year; mean.SD)  
54.3 (5.46) Duration of disease (month; mean.SD) 
2.29 (1.68) Number of swollen joints (mean.SD) 
4.13 (3.01) Number of tender joints (mean.SD)  
26.71(4.01) Body Mass Index (BMI) 
3.83 (1.76) DAS-28 
42.31(19.62) VAS (0-100 mm) 
29.95(17.86) ESR (mm/h) 
1.23 (0.86) Number of comorbidities  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2 Means, standard deviations, percent floor and ceiling effects, and Cronbach’s 
Alpha for the Iranian version of PedsQL™ 4.0 Generic Core Scales Young Adult 
Version  
Scale Number 
of Items 
Mean  SD Percent 
Floor (%) 
Percent 
Ceiling 
(%) 
Cronbach's 
α 
ICC (95% CI) 
Total Score   64.33  30.96 6.09 0 0.911 0.801 (0.734-
0.926) 
Physical 
Functioning 
8 66.15  34.68 3.6 4.2 0.822 0.907(0.803-0.973 
Emotional 
Functioning 
5 63.26  28.00 4.2 1.1 0.818 0.828(0.763-0.897) 
Social 
Functioning 
5 68.92  29.19 5.1 3.7 0.826 0.776(0.635-0.864) 
Work/School 5 61.97  34.57 9.5 0 0.843 0.864(0.728-0.923) 
Functioning 
Psychosocial 
health 
15 65.89 26.42 5.8 0 0.897 0.802(0.701-0.831) 
 
Note; All p values for the ICCs are significant at P<0.05   
ICC = Intraclass correlation coefficients 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3. Intercorrelations among PedsQL™ 4.0 Generic Core Scales Young Adult Version, VAS and SF-36 subscales  
Scale  TS PH EF SF WF PF RP BP GH VT SF RE MH PsyH VAS 
TS - 0.77 0.77 0.84 0.84 0.50 0.46 032 0.32 0.36 0.44 0.39 0.56 0.68 -0.658 
PH  - 0.86 0.75 0.81 0.75 0.68 0.53 0.41 0.31 0.46 0.37 0.50 0.53 -0.824 
EF   - 0.89 0.86 0.42 0.48 0.43 0.47 0.52 0.58 0.55 0.59 0.66 -0.629 
SF    - 0.89 0.47 0.41 0.57 0.58 0.59 0.41 0.58 0.51 0.69 -0.803 
WF     - 0.44 0.38 0.49 0.51 0.24 0.30 0.42 0.47 0.68 -0.863 
PF      - 0.69 0.56 0.51 0.74 0.53 0.47 0.58 0.47 -0.706 
RP       - 0.71 0.64 0.49 0.53 0.56 0.42 0.51 -0.552 
BP        - 0.52 0.48 0.45 0.58 0.52 0.54 -0.520 
GH         - 0.81 0.72 0.63 0.54 0.62 -0.769 
VT          - 0.59 0.68 0.56 0.60 -0.618 
SF           - 0.58 0.70 0.68 -0.709 
RE            - 0.79 0.65 -0.647 
MH             - 0.71 -0.803 
PsyH              - -0.710 
VAS               - 
 
TS =Total Generic Core Scales; PH= Physical Health Summary Score; EF= Emotional Functioning Scale; SF = Social Functioning Scale; WF= 
Work Functioning Scale; PsyH= Psychosocial health.  
All *P<0.05 
Table 4.Comparison of the PedsQL™ 4.0 Generic Core Scales Young Adult Version 
for condition categories and comorbidities   
   
 Health status  Comorbidity   
Scale rheumatoid 
arthritis 
(n=197) 
Healthy 
university 
sample  
(n=1803) 
0 
(n=125) 
≥1 
(n= 72) 
Total Score †‡  64.33 (30.96) 76.42 (15.85) 65.63(14.51) 58.69(17.42) 
Physical 
Functioning†‡ 
66.15 (34.68) 77.67(18.10) 69.07(15.17) 59.65(2185) 
Emotional 
Functioning†‡ 
63.26 (28.00) 80.28(21.92) 66.86(21.76) 54.72(21.67) 
Social 
Functioning†‡ 
68.92 (29.19) 83.83(10.02) 70.82(17.40) 62.51(19.45) 
Work/School 
Functioning†‡ 
61.97 (34.57) 73.54(20.46) 62.75(18.86) 56.87(22.98) 
Psychosocial 
health†‡ 
63.04 (28.46) 76.81(29.74) 59.24(17.81) 66.76(26.68) 
† Statistically significant according to Benjamini-Hochberg procedure for Health condition  
‡ Statistically significant according to Benjamini-Hochberg procedure for number of comorbidities  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5. Responsiveness of the PedsQL™ 4.0 Generic Core Scales Young Adult 
Version for newly diagnosed patients with rheumatoid arthritis (n=49; 17 men, 32 
women). 
 
 Baseline  First follow-
up   
Second 
follow-up   
SRM 
0-3 
months 
SRM 
3-6 
months 
Pa 
 Mean(SD) Mean(SD) Mean(SD) 
Total Score 54.37(15.64) 60.24(15.25) 69.01(14.61) 0.39 0.59 0.006 
Physical 
Functioning 
50.54(20.46) 63.03(26.18) 75.51(22.77) 0.55 0.51 0.007 
Emotional 
Functioning 
51.42(21.48) 56.88(19.34) 67.03(22.92) 0.27 0.51 0.009 
Social 
Functioning 
54.67(18.10) 
 
60.17(17.19) 71.43(15.99) 
 
 
0.30 0.67 0.002 
Work/School 
Functioning 
60.83(18.02) 71.18(19.48) 80.59(20.97) 0.57 0.48 0.001 
Psychosocial 
health 
54.26(16.65) 61.70(16.39) 72.69(16.01) 0.46 0.70 0.008 
a: repeated measure analysis of variance, SRM: Standardized Response Mean 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix A  
 
PedsQL™ 4.0 Generic Core Scales Young Adult Version Items 
_______________________________________________________________ 
Physical Functioning Scale 
1. It is hard for me to walk more than one block 
2. It is hard for me to run 
3. It is hard for me to do sports activity or exercise 
4. It is hard for me to lift something heavy 
5. It is hard for me to take a bath or shower by myself 
6. It is hard for me to do chores around the house 
7. I hurt or ache 
8. I have low energy 
Emotional Functioning Scale 
1. I feel afraid or scared 
2. I feel sad or blue 
3. I feel angry 
4. I have trouble sleeping 
5. I worry about what will happen to me 
Social Functioning Scale 
1. I have trouble getting along with other young adults 
2. Other young adults do not want to be my friend 
3. Other young adults tease me 
4. I cannot do things that others my age can do 
5. It is hard to keep up with my peers 
Work/School Functioning Scale 
1. It is hard to pay attention at work or school 
2. I forget things 
3. I have trouble keeping up with my work or studies 
4. I miss work or school because of not feeling well 
5. I miss work or school to go to the doctor or Hospital  
Reproduced with permission from J.W. Varni, Ph.D. Copyright © 1998. 
The PedsQL™ is available at http://www.pedsql.org.  
 
 
 
 
 
 
 
 
